Card #26: 🧬 Cell & Gene Therapy
Canonical URL: https://conspirograph.com/topic/covid-19/card/683
Stefan Oelrich, President of Bayer’s Pharmaceuticals Division, emphasizes the company’s investment in cell and gene therapy 🧬 as a transformative leap. He cites mRNA vaccines as an example of this innovation, noting that public acceptance of such therapies has likely increased due to the 🦠 COVID-19 pandemic. Oelrich speculates that prior to the pandemic, a survey might have shown a 95% refusal rate for gene or cell therapy injections, but the crisis has opened many people’s eyes to medical advancements. 📍 Stefan Oelrich is a German business executive born in June 1968. He serves as a member of the Board of Management of Bayer AG and President of its Pharmaceuticals Division headquartered in Berlin.
Stefan Oelrich, President of Bayer’s Pharmaceuticals Division, emphasizes the company’s investment in cell and gene therapy 🧬 as a transformative leap.
He cites mRNA vaccines as an example of this innovation, noting that public acceptance of such therapies has likely increased due to the 🦠 COVID-19 pandemic. Oelrich speculates that prior to the pandemic, a survey might have shown a 95% refusal rate for gene or cell therapy injections, but the crisis has opened many people’s eyes to medical advancements.
📍 Stefan Oelrich is a German business executive born in June 1968. He serves as a member of the Board of Management of Bayer AG and President of its Pharmaceuticals Division headquartered in Berlin.
Attachments
Topic: COVID-19. Comments: 0.